|By PR Newswire||
|September 5, 2013 06:15 PM EDT||
WAYNE, Pa., Sept. 5, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Dial Global, Inc. ("Dial Global" or the "Company") (OTC: DIAL) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Cumulus Media Inc. in a transaction valued at approximately $260 million.
Under the terms of the agreement, public shareholders of Dial will receive $0.155 per share in cash for each share of Dial they own.
If you own shares of Rochester Medical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/dial. You may also email Mr. Maniskas at email@example.com.
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by Dial's Board of Directors for not acting in the Company's shareholders' best interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com.
SOURCE Ryan & Maniskas, LLP